Works matching IS 00099104 AND DT 2019 AND VI 196 AND IP 2
Results: 14
Vaccines for emerging pathogens: from research to the clinic.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 155, doi. 10.1111/cei.13303
- By:
- Publication type:
- Article
Emerging viruses and current strategies for vaccine intervention.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 157, doi. 10.1111/cei.13295
- By:
- Publication type:
- Article
HLA‐E: exploiting pathogen‐host interactions for vaccine development.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 167, doi. 10.1111/cei.13292
- By:
- Publication type:
- Article
Novel approaches for the design, delivery and administration of vaccine technologies.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 189, doi. 10.1111/cei.13287
- By:
- Publication type:
- Article
Novel multi‐component vaccine approaches for Burkholderia pseudomallei.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 178, doi. 10.1111/cei.13286
- By:
- Publication type:
- Article
Mucosal vaccines and technology.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 205, doi. 10.1111/cei.13285
- By:
- Publication type:
- Article
Natural killer cell expression of Ki67 is associated with elevated serum IL‐15, disease activity and nephritis in systemic lupus erythematosus.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 226, doi. 10.1111/cei.13263
- By:
- Publication type:
- Article
A single administration of human adipose tissue‐derived mesenchymal stromal cells (MSC) induces durable and sustained long‐term regulation of inflammatory response in experimental colitis.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 139, doi. 10.1111/cei.13262
- By:
- Publication type:
- Article
Immunogenicity assay development and validation for biological therapy as exemplified by ustekinumab.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 259, doi. 10.1111/cei.13261
- By:
- Publication type:
- Article
High concentrations of atorvastatin reduce in‐vitro function of conventional T and regulatory T cells.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 237, doi. 10.1111/cei.13260
- By:
- Publication type:
- Article
Vasoactive intestinal peptide is required in the maintenance of immune regulatory competency of immune regulatory monocytes.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 276, doi. 10.1111/cei.13259
- By:
- Publication type:
- Article
Novel small molecule IL‐6 inhibitor suppresses autoreactive Th17 development and promotes T<sub>reg</sub> development.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 215, doi. 10.1111/cei.13258
- By:
- Publication type:
- Article
Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren's syndrome and other sarcoidosis.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. 249, doi. 10.1111/cei.13257
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 196, n. 2, p. N.PAG, doi. 10.1111/cei.13172
- Publication type:
- Article